ABL Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Abbott Laboratories

Watchlist Manager

Watchlist

Price: 84.72 EUR -0.75% Market Closed

Market Cap: €147.4B

A	Abbott Laboratories F:ABL	US
R	Resona Holdings Inc F:DW1	JP
G	Great-West Lifeco Inc F:GWS	CA
S	Sprint Bioscience AB XMUN:5JA1	SE
S	StreaksAI PLC F:NM1	UK
C	Conagra Brands Inc F:CAO	US
C	Chocoladefabriken Lindt & Spruengli AG DUS:LSPP	CH
A	Aristocrat Leisure Ltd XMUN:AC8	AU
	Bloom Energy Corp NYSE:BE	US
	Molecular Templates Inc OTC:MTEM	US

Profitability Summary

Abbott Laboratories's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

56%

Strong 3Y Average Gross Margin

56%

Gross Margin is Increasing

55% > 56%

Healthy Operating Margin

19%

Sustainable 3Y Average Operating Margin

17%

Operating Margin is Increasing

16% > 19%

Healthy Net Margin

14%

Sustainable 3Y Average Net Margin

20%

Net Margin is Increasing

13% > 14%

Exceptional Free Cash Flow Margin

16%

Strong 3Y Average Free Cash Flow Margin

15%

Free Cash Flow Margin is Increasing

14% > 16%

Positive ROE

12%

Positive 3Y Average ROE

Positive 3Y Average ROIC

13%

ROIC is Increasing

9% > 9%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.